HK

Harish Kumar

Active Director Director DIN 08936197
DIN 08936197 First appointment Oct 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2020
Shareholding value •••• Premium profile

About Harish Kumar

Data last updated:

Harish Kumar is a Director at Ramadico Pharmaceuticals Private Limited (since 2020). The company operates in Pharma. Ramadico Pharmaceuticals Private Limited reported revenue of ₹11.3 Lakh (FY 2024).

DIN 08936197
Primary Designation Director
Industry Pharma
First Appointment 27 Oct 2020
Oldest Company Age 14 yrs
Largest company Ramadico Pharmaceuticals Private Limited · ₹11.3 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director27 Oct 20202012₹11.3 Lakh (FY 2024)Active

Board colleagues of Harish Kumar

NameDINCompanyDesignation
Sandeep08936196Ramadico Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ramadico Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Harish Kumar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harish Kumar

Harish Kumar currently holds 1 directorship: Ramadico Pharmaceuticals Private Limited (Director, since 27 Oct 2020, revenue ₹11.3 Lakh (FY 2024)).

Harish Kumar was first appointed on 27 Oct 2020 as Director at Ramadico Pharmaceuticals Private Limited.

The current boards of Harish Kumar's companies include Sandeep (Ramadico Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available